Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO18519 | Nothapodytes pittosporoides | Species | Icacinaceae | Eukaryota | TCMID* | |||
NPO12582 | Camptotheca acuminata | Species | Nyssaceae | Eukaryota | TCMID* | |||
NPO12582 | Camptotheca acuminata | Species | Nyssaceae | Eukaryota | TCM_Taiwan* | |||
NPO12582 | Camptotheca acuminata | Species | Nyssaceae | Eukaryota | HerDing* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT604 | Individual Protein | Serum albumin | Homo sapiens | Activity | = | 1.7 | 8289200 | |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 12 | nM | 12565975 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 36.5 | % | 12565975 |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | CC50 | = | 1000 | nM | 1846923 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 18 | nM | 1846923 |
NPT32 | Organism | Mus musculus | Mus musculus | Therapeutic index | = | 8 | 7381856 | |
NPT2 | Others | Unspecified | ED50 | = | 0.02 | ug/ml | 7381856 | |
NPT3804 | Cell Line | Human Tumor Cell lines | GI50 | = | 36 | nM | 11052802 | |
NPT143 | Individual Protein | DNA topoisomerase I | Homo sapiens | IC50 | = | 110 | nM | 8410981 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 16 | % | 8355258 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 4 | % | 8355258 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 6 | % | 8355258 |
NPT605 | Organism | Homo sapiens | Homo sapiens | Activity | = | 1.7 | 8355258 | |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 2470 | nM | 15808456 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 148 | nM | 15808456 |
NPT547 | Cell Line | BGC-823 | Homo sapiens | Activity | = | 4.78 | % | 17997321 |
NPT547 | Cell Line | BGC-823 | Homo sapiens | Activity | = | 13.2 | % | 17997321 |
NPT547 | Cell Line | BGC-823 | Homo sapiens | Activity | = | 6.47 | % | 17997321 |
NPT547 | Cell Line | BGC-823 | Homo sapiens | Activity | = | 3.72 | % | 17997321 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 5.4 | nM | 18318465 |
NPT407 | Cell Line | COLO 205 | Homo sapiens | IC50 | = | 9.1 | nM | 18318465 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 8.8 | nM | 18318465 |
NPT2 | Others | Unspecified | IC50 | = | 6.9 | nM | 18318465 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 0.024 | ug/ml | 15104494 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 0.62 | ug/ml | 15104494 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 410 | nM | 17067169 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 280 | nM | 17067169 |
NPT2 | Others | Unspecified | IC50 | = | 6490 | nM | 16933867 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 19120 | nM | 16933867 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 38550 | nM | 16933867 |
NPT395 | Cell Line | SF-268 | Homo sapiens | IC50 | = | 29880 | nM | 16933867 |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 4100 | nM | 19133759 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 400 | nM | 19133759 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 110 | nM | 19541483 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 210 | nM | 19541483 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 600 | nM | 19715319 |
NPT179 | Cell Line | A2780 | Homo sapiens | IC50 | = | 700 | nM | 19715319 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 200 | nM | 19715319 |
NPT2 | Others | Unspecified | IC50 | = | 370 | nM | 19423199 | |
NPT2 | Others | Unspecified | IC50 | = | 1090 | nM | 19423199 | |
NPT659 | Cell Line | SMMC-7721 | Homo sapiens | IC50 | = | 140 | nM | 19842682 |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 160 | nM | 20184290 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 360 | nM | 20184290 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 3700 | nM | 20402524 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 40 | nM | 20402524 |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 30 | nM | 20402524 |
NPT466 | Cell Line | U-937 | Homo sapiens | IC50 | = | 110 | nM | 20402524 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PubChem BioAssay data set | |
NPT1226 | Individual Protein | Caspase-7 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 50.1 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 7079.5 | nM | PubChem BioAssay data set |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT2930 | Individual Protein | Hemoglobin beta chain | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 1584.9 | nM | PubChem BioAssay data set |
NPT277 | Individual Protein | Caspase-1 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 829 | nM | 21414778 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 981 | nM | 21414778 |
NPT2 | Others | Unspecified | IC50 | = | 496 | nM | 21414778 | |
NPT2 | Others | Unspecified | IC50 | = | 230 | nM | 21600681 | |
NPT2 | Others | Unspecified | IC50 | = | 1040 | nM | 21600681 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Inhibition | = | 92 | % | 21807514 |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 12.85 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 141.58 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 11.56 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 17.58 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 23.44 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 27.73 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 16.07 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 8.26 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 27.61 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 49.77 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 86.3 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 31.48 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 45.71 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 9.441 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 23.17 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 10.91 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 7.499 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 46.99 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 14.16 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 866.96 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 8.414 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 17.7 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 2685.34 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 24.6 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 51.29 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 10.54 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 105.44 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 33.57 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 26.24 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 106.91 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 156.31 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 92.04 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 33.73 | nM | PubChem BioAssay data set | |
NPT168 | Cell Line | P388 | Mus musculus | GI50 | 20.32 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 54.33 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 473.15 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 50.58 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 83.37 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 35.16 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 14 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 295.12 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 15.67 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 16.41 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 83.95 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 62.95 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 7.499 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 150.31 | nM | PubChem BioAssay data set | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 13.61 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 22.7 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 13.93 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 7.499 | nM | PubChem BioAssay data set | |
NPT552 | Cell Line | P388/ADR | Mus musculus | GI50 | 30.41 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 45.29 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 9.705 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 476.43 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 18.41 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 24.1 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 1042.32 | nM | PubChem BioAssay data set | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 23.12 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 41.21 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 247.74 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 7.499 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 1196.74 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 13.4 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 118.3 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 74.47 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 23.6 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 125.31 | nM | PubChem BioAssay data set | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 109.14 | nM | PubChem BioAssay data set | |
NPT738 | Cell Line | SN12K1 | Homo sapiens | GI50 | 10 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 31.2 | nM | 22647222 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 33.6 | nM | 22647222 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | GI | = | 29.1 | % | 23124210 |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | GI | = | 28.1 | % | 23124210 |
NPT886 | Cell Line | NIH3T3 | Mus musculus | GI | = | 9.3 | % | 23124210 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | IC50 | > | 20000 | nM | 23124210 |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | IC50 | > | 20000 | nM | 23124210 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 17.37 | % | 23124210 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 18.66 | % | 23124210 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 24.95 | % | 23124210 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 78 | nM | 22959246 |
NPT179 | Cell Line | A2780 | Homo sapiens | IC50 | = | 4 | nM | 22959246 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | -5.24 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 6.63 | % | 23062825 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 29500 | nM | 23092389 |
NPT2 | Others | Unspecified | IC50 | = | 21300 | nM | 23092389 | |
NPT2 | Others | Unspecified | Potency | 58 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 20.6 | nM | PubChem BioAssay data set | ||
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 600 | nM | 23566520 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 300 | nM | 23566520 |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 200 | nM | 23566520 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 70 | nM | 23566520 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 60 | nM | 23566520 |
NPT1083 | Cell Line | A-375 | Homo sapiens | IC50 | = | 150 | nM | 23639650 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 300 | nM | 23639650 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 250 | nM | 23639650 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 17 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 8.3 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 38.2 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 19.8 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 12.8 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 11.9 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 7.4 | % | 23811258 |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 5.7 | % | 23811258 |
NPT65 | Cell Line | HepG2 | Homo sapiens | GI | = | 85.4 | % | 24012683 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 24.5 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 7.6 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 4.7 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 8.6 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 5.8 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 2 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 3 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 1.8 | % | 10.1007/s00044-013-0854-3 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 1.2 | % | 10.1007/s00044-013-0854-3 |
NPT2 | Others | Unspecified | Potency | 112.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1258.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 251.2 | nM | PubChem BioAssay data set | ||
NPT306 | Cell Line | PC-3 | Homo sapiens | GI | = | 17.1 | % | 10.1039/C1MD00038A |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI | = | 37 | % | 10.1039/C1MD00038A |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | GI | = | 8.8 | % | 10.1039/C1MD00038A |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | GI | = | 33.5 | % | 10.1039/C1MD00038A |
NPT2 | Others | Unspecified | GI | = | 7.3 | % | 10.1039/C1MD00038A | |
NPT2 | Others | Unspecified | GI | = | 26.5 | % | 10.1039/C1MD00038A | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 128 | nM | 25481395 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 499 | nM | 25481395 |
NPT2 | Others | Unspecified | IC50 | = | 181 | nM | 25481395 | |
NPT2 | Others | Unspecified | IC50 | = | 835 | nM | 25481395 | |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 1.3 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 1.8 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 3.5 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 2.1 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 6 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 9.1 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 3.8 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 7.3 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | Activity | = | 18.6 | % | 25064351 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | IC50 | = | 29100 | nM | 25874331 |
NPT2 | Others | Unspecified | IC50 | = | 34500 | nM | 25874331 | |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | IC50 | = | 28100 | nM | 25874331 |
NPT1174 | Cell Line | A375 | Homo sapiens | IC50 | = | 27800 | nM | 25874331 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 48200 | nM | 25874331 |
NPT3140 | Cell Line | MGC-803 | Homo sapiens | IC50 | = | 29100 | nM | 26280921 |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 34500 | nM | 26280921 |
NPT1872 | Cell Line | Bcap37 | Homo sapiens | IC50 | = | 28100 | nM | 26280921 |
NPT1174 | Cell Line | A375 | Homo sapiens | IC50 | = | 27800 | nM | 26280921 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 48200 | nM | 26280921 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 82 | nM | 26725027 |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 2270 | nM | 26725027 |
NPT2 | Others | Unspecified | IC50 | = | 58620 | nM | 26725027 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC151781 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC316181 |
1.0 | High Similarity | NPC74562 |
0.901 | High Similarity | NPC128115 |
0.8942 | High Similarity | NPC129909 |
0.8639 | High Similarity | NPC61435 |
0.8632 | High Similarity | NPC311858 |
0.8622 | High Similarity | NPC192674 |
0.8526 | High Similarity | NPC470003 |
0.8263 | Intermediate Similarity | NPC28848 |
0.8263 | Intermediate Similarity | NPC14325 |
0.7799 | Intermediate Similarity | NPC53344 |
0.7778 | Intermediate Similarity | NPC211813 |
0.7751 | Intermediate Similarity | NPC474145 |
0.7751 | Intermediate Similarity | NPC475841 |
0.7725 | Intermediate Similarity | NPC477548 |
0.77 | Intermediate Similarity | NPC472098 |
0.7696 | Intermediate Similarity | NPC472099 |
0.7681 | Intermediate Similarity | NPC249040 |
0.7667 | Intermediate Similarity | NPC472111 |
0.7644 | Intermediate Similarity | NPC477549 |
0.7594 | Intermediate Similarity | NPC82548 |
0.7593 | Intermediate Similarity | NPC469928 |
0.7577 | Intermediate Similarity | NPC474183 |
0.7577 | Intermediate Similarity | NPC470785 |
0.7577 | Intermediate Similarity | NPC470784 |
0.7566 | Intermediate Similarity | NPC272549 |
0.7547 | Intermediate Similarity | NPC270918 |
0.7533 | Intermediate Similarity | NPC184680 |
0.7532 | Intermediate Similarity | NPC472435 |
0.7524 | Intermediate Similarity | NPC295898 |
0.7524 | Intermediate Similarity | NPC276517 |
0.7489 | Intermediate Similarity | NPC157931 |
0.7488 | Intermediate Similarity | NPC476098 |
0.7464 | Intermediate Similarity | NPC280714 |
0.7437 | Intermediate Similarity | NPC472436 |
0.7416 | Intermediate Similarity | NPC239954 |
0.7416 | Intermediate Similarity | NPC212213 |
0.7406 | Intermediate Similarity | NPC53144 |
0.7406 | Intermediate Similarity | NPC200836 |
0.7402 | Intermediate Similarity | NPC66083 |
0.7401 | Intermediate Similarity | NPC323752 |
0.7401 | Intermediate Similarity | NPC323198 |
0.7399 | Intermediate Similarity | NPC473449 |
0.7391 | Intermediate Similarity | NPC475816 |
0.7387 | Intermediate Similarity | NPC478141 |
0.7383 | Intermediate Similarity | NPC88008 |
0.7378 | Intermediate Similarity | NPC311906 |
0.7373 | Intermediate Similarity | NPC264176 |
0.7368 | Intermediate Similarity | NPC156704 |
0.7353 | Intermediate Similarity | NPC194040 |
0.7348 | Intermediate Similarity | NPC82472 |
0.7333 | Intermediate Similarity | NPC168911 |
0.7315 | Intermediate Similarity | NPC469589 |
0.7313 | Intermediate Similarity | NPC14288 |
0.7302 | Intermediate Similarity | NPC193238 |
0.7289 | Intermediate Similarity | NPC319232 |
0.7289 | Intermediate Similarity | NPC24370 |
0.7286 | Intermediate Similarity | NPC90229 |
0.7285 | Intermediate Similarity | NPC96321 |
0.7284 | Intermediate Similarity | NPC99891 |
0.7281 | Intermediate Similarity | NPC475720 |
0.7281 | Intermediate Similarity | NPC474192 |
0.7273 | Intermediate Similarity | NPC148183 |
0.7273 | Intermediate Similarity | NPC152768 |
0.7269 | Intermediate Similarity | NPC287208 |
0.7265 | Intermediate Similarity | NPC472434 |
0.7257 | Intermediate Similarity | NPC473800 |
0.7257 | Intermediate Similarity | NPC34580 |
0.7257 | Intermediate Similarity | NPC257851 |
0.7257 | Intermediate Similarity | NPC118559 |
0.7257 | Intermediate Similarity | NPC124920 |
0.7257 | Intermediate Similarity | NPC304307 |
0.7255 | Intermediate Similarity | NPC320394 |
0.7243 | Intermediate Similarity | NPC223427 |
0.7235 | Intermediate Similarity | NPC476116 |
0.7235 | Intermediate Similarity | NPC174672 |
0.7235 | Intermediate Similarity | NPC174758 |
0.7232 | Intermediate Similarity | NPC280272 |
0.7225 | Intermediate Similarity | NPC198673 |
0.7225 | Intermediate Similarity | NPC100547 |
0.7225 | Intermediate Similarity | NPC230403 |
0.722 | Intermediate Similarity | NPC478006 |
0.7209 | Intermediate Similarity | NPC329708 |
0.7209 | Intermediate Similarity | NPC475070 |
0.7209 | Intermediate Similarity | NPC47059 |
0.7209 | Intermediate Similarity | NPC165349 |
0.7209 | Intermediate Similarity | NPC274291 |
0.7209 | Intermediate Similarity | NPC264166 |
0.7209 | Intermediate Similarity | NPC118832 |
0.7207 | Intermediate Similarity | NPC469594 |
0.7207 | Intermediate Similarity | NPC303658 |
0.7202 | Intermediate Similarity | NPC85273 |
0.7202 | Intermediate Similarity | NPC471304 |
0.7195 | Intermediate Similarity | NPC330009 |
0.7193 | Intermediate Similarity | NPC322135 |
0.7193 | Intermediate Similarity | NPC223409 |
0.7193 | Intermediate Similarity | NPC95240 |
0.7186 | Intermediate Similarity | NPC65080 |
0.7185 | Intermediate Similarity | NPC181081 |
0.7184 | Intermediate Similarity | NPC315467 |
0.7182 | Intermediate Similarity | NPC471080 |
0.7182 | Intermediate Similarity | NPC469592 |
0.7181 | Intermediate Similarity | NPC261251 |
0.7175 | Intermediate Similarity | NPC313804 |
0.7175 | Intermediate Similarity | NPC315804 |
0.7174 | Intermediate Similarity | NPC284888 |
0.7168 | Intermediate Similarity | NPC21638 |
0.7167 | Intermediate Similarity | NPC303374 |
0.7162 | Intermediate Similarity | NPC469727 |
0.7156 | Intermediate Similarity | NPC220851 |
0.7154 | Intermediate Similarity | NPC478009 |
0.7154 | Intermediate Similarity | NPC478010 |
0.7149 | Intermediate Similarity | NPC194740 |
0.7149 | Intermediate Similarity | NPC471762 |
0.7143 | Intermediate Similarity | NPC79293 |
0.7143 | Intermediate Similarity | NPC279401 |
0.7137 | Intermediate Similarity | NPC214142 |
0.713 | Intermediate Similarity | NPC54803 |
0.713 | Intermediate Similarity | NPC321592 |
0.713 | Intermediate Similarity | NPC314270 |
0.7125 | Intermediate Similarity | NPC314882 |
0.7125 | Intermediate Similarity | NPC329982 |
0.7123 | Intermediate Similarity | NPC309845 |
0.7123 | Intermediate Similarity | NPC5145 |
0.7122 | Intermediate Similarity | NPC176127 |
0.7115 | Intermediate Similarity | NPC183805 |
0.7109 | Intermediate Similarity | NPC57994 |
0.7109 | Intermediate Similarity | NPC289299 |
0.7105 | Intermediate Similarity | NPC186351 |
0.7104 | Intermediate Similarity | NPC266931 |
0.7103 | Intermediate Similarity | NPC329793 |
0.7103 | Intermediate Similarity | NPC315491 |
0.7103 | Intermediate Similarity | NPC45459 |
0.7101 | Intermediate Similarity | NPC171171 |
0.7101 | Intermediate Similarity | NPC204385 |
0.71 | Intermediate Similarity | NPC141053 |
0.7098 | Intermediate Similarity | NPC74360 |
0.7097 | Intermediate Similarity | NPC277350 |
0.7094 | Intermediate Similarity | NPC283152 |
0.7089 | Intermediate Similarity | NPC306376 |
0.7089 | Intermediate Similarity | NPC469734 |
0.7085 | Intermediate Similarity | NPC305984 |
0.7083 | Intermediate Similarity | NPC189079 |
0.7079 | Intermediate Similarity | NPC312872 |
0.7076 | Intermediate Similarity | NPC316224 |
0.7076 | Intermediate Similarity | NPC188400 |
0.7075 | Intermediate Similarity | NPC245916 |
0.7072 | Intermediate Similarity | NPC16066 |
0.707 | Intermediate Similarity | NPC471944 |
0.7069 | Intermediate Similarity | NPC33064 |
0.7069 | Intermediate Similarity | NPC245055 |
0.7064 | Intermediate Similarity | NPC474905 |
0.7056 | Intermediate Similarity | NPC241024 |
0.7056 | Intermediate Similarity | NPC32200 |
0.7053 | Intermediate Similarity | NPC314002 |
0.7047 | Intermediate Similarity | NPC260909 |
0.7044 | Intermediate Similarity | NPC288943 |
0.7042 | Intermediate Similarity | NPC133609 |
0.704 | Intermediate Similarity | NPC274982 |
0.704 | Intermediate Similarity | NPC322064 |
0.7037 | Intermediate Similarity | NPC123019 |
0.7031 | Intermediate Similarity | NPC470126 |
0.7027 | Intermediate Similarity | NPC478074 |
0.7026 | Intermediate Similarity | NPC220852 |
0.7024 | Intermediate Similarity | NPC24864 |
0.7023 | Intermediate Similarity | NPC213308 |
0.7019 | Intermediate Similarity | NPC66210 |
0.7018 | Intermediate Similarity | NPC472287 |
0.7018 | Intermediate Similarity | NPC472286 |
0.7014 | Intermediate Similarity | NPC99666 |
0.7014 | Intermediate Similarity | NPC55493 |
0.7012 | Intermediate Similarity | NPC478012 |
0.7012 | Intermediate Similarity | NPC478011 |
0.701 | Intermediate Similarity | NPC326575 |
0.7009 | Intermediate Similarity | NPC285343 |
0.7009 | Intermediate Similarity | NPC184225 |
0.7009 | Intermediate Similarity | NPC312645 |
0.7009 | Intermediate Similarity | NPC102008 |
0.7005 | Intermediate Similarity | NPC204717 |
0.7005 | Intermediate Similarity | NPC317572 |
0.7005 | Intermediate Similarity | NPC476115 |
0.7004 | Intermediate Similarity | NPC314056 |
0.7 | Intermediate Similarity | NPC66777 |
0.7 | Intermediate Similarity | NPC144381 |
0.6996 | Remote Similarity | NPC477979 |
0.6995 | Remote Similarity | NPC303225 |
0.699 | Remote Similarity | NPC206201 |
0.6986 | Remote Similarity | NPC472323 |
0.6986 | Remote Similarity | NPC321428 |
0.6984 | Remote Similarity | NPC314176 |
0.6982 | Remote Similarity | NPC112206 |
0.6982 | Remote Similarity | NPC235900 |
0.6982 | Remote Similarity | NPC202605 |
0.6981 | Remote Similarity | NPC307963 |
0.6976 | Remote Similarity | NPC72980 |
0.6974 | Remote Similarity | NPC26872 |
0.6971 | Remote Similarity | NPC313587 |
0.6971 | Remote Similarity | NPC315893 |
0.6971 | Remote Similarity | NPC316110 |
0.6964 | Remote Similarity | NPC74969 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC151781 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9947 | High Similarity | NPD4897 | Phase 2 |
0.9643 | High Similarity | NPD5506 | Approved |
0.9643 | High Similarity | NPD5507 | Approved |
0.9216 | High Similarity | NPD7589 | Clinical (unspecified phase) |
0.9126 | High Similarity | NPD7796 | Approved |
0.9126 | High Similarity | NPD7797 | Approved |
0.9026 | High Similarity | NPD4901 | Clinical (unspecified phase) |
0.8942 | High Similarity | NPD3785 | Clinical (unspecified phase) |
0.8711 | High Similarity | NPD6206 | Phase 1 |
0.8692 | High Similarity | NPD7025 | Clinical (unspecified phase) |
0.8667 | High Similarity | NPD6261 | Phase 3 |
0.8657 | High Similarity | NPD4900 | Clinical (unspecified phase) |
0.8632 | High Similarity | NPD5444 | Phase 1 |
0.8622 | High Similarity | NPD6249 | Phase 2 |
0.8622 | High Similarity | NPD3800 | Clinical (unspecified phase) |
0.8622 | High Similarity | NPD6248 | Phase 2 |
0.845 | Intermediate Similarity | NPD5487 | Phase 1 |
0.8446 | Intermediate Similarity | NPD4334 | Discontinued |
0.8358 | Intermediate Similarity | NPD3777 | Phase 3 |
0.8223 | Intermediate Similarity | NPD4315 | Phase 2 |
0.8119 | Intermediate Similarity | NPD5427 | Suspended |
0.7981 | Intermediate Similarity | NPD5834 | Phase 3 |
0.7981 | Intermediate Similarity | NPD5835 | Phase 3 |
0.77 | Intermediate Similarity | NPD7573 | Discontinued |
0.7653 | Intermediate Similarity | NPD6567 | Clinical (unspecified phase) |
0.7547 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7512 | Intermediate Similarity | NPD7218 | Clinical (unspecified phase) |
0.7489 | Intermediate Similarity | NPD8463 | Approved |
0.7489 | Intermediate Similarity | NPD4328 | Approved |
0.7466 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.744 | Intermediate Similarity | NPD4418 | Discontinued |
0.7415 | Intermediate Similarity | NPD3321 | Discontinued |
0.7413 | Intermediate Similarity | NPD4204 | Approved |
0.7413 | Intermediate Similarity | NPD4203 | Approved |
0.7389 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD7538 | Clinical (unspecified phase) |
0.7306 | Intermediate Similarity | NPD5293 | Phase 2 |
0.7302 | Intermediate Similarity | NPD7453 | Approved |
0.7302 | Intermediate Similarity | NPD7452 | Approved |
0.7301 | Intermediate Similarity | NPD7710 | Clinical (unspecified phase) |
0.7269 | Intermediate Similarity | NPD5658 | Approved |
0.7257 | Intermediate Similarity | NPD7268 | Clinical (unspecified phase) |
0.7253 | Intermediate Similarity | NPD6716 | Phase 1 |
0.7252 | Intermediate Similarity | NPD3258 | Approved |
0.7249 | Intermediate Similarity | NPD4373 | Phase 2 |
0.7248 | Intermediate Similarity | NPD5416 | Discontinued |
0.7246 | Intermediate Similarity | NPD8102 | Discontinued |
0.7225 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD3263 | Phase 3 |
0.7209 | Intermediate Similarity | NPD4035 | Approved |
0.7209 | Intermediate Similarity | NPD32 | Approved |
0.7209 | Intermediate Similarity | NPD4033 | Approved |
0.7209 | Intermediate Similarity | NPD4122 | Approved |
0.7209 | Intermediate Similarity | NPD4037 | Approved |
0.7209 | Intermediate Similarity | NPD4039 | Approved |
0.7209 | Intermediate Similarity | NPD31 | Approved |
0.7209 | Intermediate Similarity | NPD4036 | Approved |
0.7209 | Intermediate Similarity | NPD4034 | Approved |
0.7209 | Intermediate Similarity | NPD4038 | Approved |
0.7207 | Intermediate Similarity | NPD7395 | Discontinued |
0.7206 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.7205 | Intermediate Similarity | NPD4885 | Approved |
0.7189 | Intermediate Similarity | NPD2916 | Discontinued |
0.7174 | Intermediate Similarity | NPD5040 | Clinical (unspecified phase) |
0.7171 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD4987 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD6247 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD8017 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD8016 | Phase 3 |
0.7162 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7161 | Intermediate Similarity | NPD5488 | Discontinued |
0.7156 | Intermediate Similarity | NPD8356 | Approved |
0.7156 | Intermediate Similarity | NPD5512 | Phase 3 |
0.715 | Intermediate Similarity | NPD3390 | Phase 2 |
0.7149 | Intermediate Similarity | NPD5559 | Phase 2 |
0.7143 | Intermediate Similarity | NPD8479 | Phase 2 |
0.7137 | Intermediate Similarity | NPD7603 | Discontinued |
0.7136 | Intermediate Similarity | NPD5075 | Discontinued |
0.7136 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.713 | Intermediate Similarity | NPD6138 | Clinical (unspecified phase) |
0.7129 | Intermediate Similarity | NPD5104 | Approved |
0.7123 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.7121 | Intermediate Similarity | NPD2915 | Discontinued |
0.7118 | Intermediate Similarity | NPD4952 | Phase 3 |
0.7117 | Intermediate Similarity | NPD5612 | Discontinued |
0.7116 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.711 | Intermediate Similarity | NPD6376 | Discontinued |
0.7109 | Intermediate Similarity | NPD4602 | Approved |
0.7105 | Intermediate Similarity | NPD8430 | Approved |
0.7103 | Intermediate Similarity | NPD484 | Approved |
0.7098 | Intermediate Similarity | NPD2882 | Phase 1 |
0.7097 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7094 | Intermediate Similarity | NPD6159 | Phase 2 |
0.708 | Intermediate Similarity | NPD6209 | Approved |
0.7075 | Intermediate Similarity | NPD6550 | Discontinued |
0.7072 | Intermediate Similarity | NPD3257 | Approved |
0.7067 | Intermediate Similarity | NPD2383 | Phase 1 |
0.7064 | Intermediate Similarity | NPD5429 | Discontinued |
0.7061 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7059 | Intermediate Similarity | NPD7069 | Discontinued |
0.7054 | Intermediate Similarity | NPD3354 | Phase 2 |
0.7054 | Intermediate Similarity | NPD8370 | Discontinued |
0.7051 | Intermediate Similarity | NPD3946 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD7548 | Discontinued |
0.7047 | Intermediate Similarity | NPD8460 | Approved |
0.7047 | Intermediate Similarity | NPD8459 | Approved |
0.7042 | Intermediate Similarity | NPD5003 | Discontinued |
0.7033 | Intermediate Similarity | NPD6965 | Clinical (unspecified phase) |
0.7028 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD4396 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD3925 | Approved |
0.7013 | Intermediate Similarity | NPD6962 | Phase 2 |
0.7013 | Intermediate Similarity | NPD7284 | Clinical (unspecified phase) |
0.7009 | Intermediate Similarity | NPD53 | Approved |
0.7009 | Intermediate Similarity | NPD7889 | Clinical (unspecified phase) |
0.7009 | Intermediate Similarity | NPD7778 | Approved |
0.7009 | Intermediate Similarity | NPD7777 | Approved |
0.7005 | Intermediate Similarity | NPD5513 | Phase 2 |
0.7 | Intermediate Similarity | NPD4081 | Clinical (unspecified phase) |
0.6991 | Remote Similarity | NPD6242 | Discontinued |
0.6987 | Remote Similarity | NPD5640 | Discontinued |
0.6982 | Remote Similarity | NPD5866 | Approved |
0.6981 | Remote Similarity | NPD1038 | Approved |
0.6981 | Remote Similarity | NPD1304 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD8405 | Clinical (unspecified phase) |
0.6975 | Remote Similarity | NPD5483 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD7022 | Phase 2 |
0.6957 | Remote Similarity | NPD8467 | Approved |
0.6957 | Remote Similarity | NPD8465 | Approved |
0.6957 | Remote Similarity | NPD8466 | Approved |
0.6957 | Remote Similarity | NPD4086 | Phase 1 |
0.6947 | Remote Similarity | NPD7194 | Discontinued |
0.6939 | Remote Similarity | NPD7955 | Approved |
0.6939 | Remote Similarity | NPD7956 | Approved |
0.6929 | Remote Similarity | NPD3809 | Discontinued |
0.6923 | Remote Similarity | NPD7807 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6476 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6158 | Phase 2 |
0.692 | Remote Similarity | NPD4667 | Clinical (unspecified phase) |
0.692 | Remote Similarity | NPD5417 | Clinical (unspecified phase) |
0.6919 | Remote Similarity | NPD2565 | Phase 2 |
0.6919 | Remote Similarity | NPD2564 | Approved |
0.6914 | Remote Similarity | NPD4926 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD4511 | Phase 1 |
0.691 | Remote Similarity | NPD7031 | Phase 1 |
0.6909 | Remote Similarity | NPD6838 | Clinical (unspecified phase) |
0.6903 | Remote Similarity | NPD5632 | Approved |
0.6894 | Remote Similarity | NPD7853 | Phase 2 |
0.689 | Remote Similarity | NPD8429 | Approved |
0.689 | Remote Similarity | NPD8428 | Approved |
0.689 | Remote Similarity | NPD8427 | Approved |
0.6889 | Remote Similarity | NPD7112 | Discontinued |
0.6887 | Remote Similarity | NPD1924 | Approved |
0.6884 | Remote Similarity | NPD6988 | Phase 1 |
0.6883 | Remote Similarity | NPD4845 | Discontinued |
0.688 | Remote Similarity | NPD8421 | Discontinued |
0.6875 | Remote Similarity | NPD3243 | Approved |
0.6875 | Remote Similarity | NPD3794 | Approved |
0.6875 | Remote Similarity | NPD3795 | Approved |
0.6872 | Remote Similarity | NPD7203 | Clinical (unspecified phase) |
0.6872 | Remote Similarity | NPD7859 | Phase 2 |
0.6866 | Remote Similarity | NPD5497 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD4501 | Approved |
0.6866 | Remote Similarity | NPD4601 | Approved |
0.6866 | Remote Similarity | NPD4500 | Approved |
0.6866 | Remote Similarity | NPD4600 | Approved |
0.6864 | Remote Similarity | NPD5601 | Phase 2 |
0.6864 | Remote Similarity | NPD6732 | Clinical (unspecified phase) |
0.6864 | Remote Similarity | NPD3003 | Approved |
0.686 | Remote Similarity | NPD5897 | Approved |
0.686 | Remote Similarity | NPD5899 | Approved |
0.686 | Remote Similarity | NPD5898 | Approved |
0.686 | Remote Similarity | NPD8101 | Phase 3 |
0.6858 | Remote Similarity | NPD3440 | Clinical (unspecified phase) |
0.6858 | Remote Similarity | NPD4989 | Phase 2 |
0.6857 | Remote Similarity | NPD6961 | Discontinued |
0.6854 | Remote Similarity | NPD6569 | Phase 2 |
0.6853 | Remote Similarity | NPD5014 | Discontinued |
0.6851 | Remote Similarity | NPD6963 | Approved |
0.6851 | Remote Similarity | NPD6964 | Approved |
0.6849 | Remote Similarity | NPD6991 | Approved |
0.6849 | Remote Similarity | NPD6176 | Phase 1 |
0.6848 | Remote Similarity | NPD8426 | Approved |
0.6848 | Remote Similarity | NPD8425 | Approved |
0.6846 | Remote Similarity | NPD6276 | Discontinued |
0.6846 | Remote Similarity | NPD7868 | Clinical (unspecified phase) |
0.6846 | Remote Similarity | NPD7996 | Phase 2 |
0.6844 | Remote Similarity | NPD5148 | Clinical (unspecified phase) |
0.6844 | Remote Similarity | NPD5149 | Phase 2 |
0.6842 | Remote Similarity | NPD7708 | Approved |
0.6835 | Remote Similarity | NPD7729 | Clinical (unspecified phase) |
0.6829 | Remote Similarity | NPD8091 | Phase 3 |
0.6828 | Remote Similarity | NPD6568 | Discontinued |
0.6825 | Remote Similarity | NPD6393 | Clinical (unspecified phase) |
0.6825 | Remote Similarity | NPD6141 | Clinical (unspecified phase) |
0.6824 | Remote Similarity | NPD5022 | Discontinued |
0.682 | Remote Similarity | NPD2176 | Approved |
0.682 | Remote Similarity | NPD2177 | Approved |
0.682 | Remote Similarity | NPD2175 | Phase 3 |
0.682 | Remote Similarity | NPD1768 | Approved |
PubChem CID   | 97226 |
ChEMBL   | CHEMBL273862 |
ZINC   |
Molecular Weight:   | 364.11 |
ALogP:   | -2.0473 |
MLogP:   | 2.89 |
XLogP:   | 0.959 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 99.96 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 27 |